A neurodegeneration gene, WDR45, links impaired ferritinophagy to iron accumulation

Citations Over TimeTop 11% of 2021 papers

Abstract

Neurodegeneration with brain iron accumulation (NBIA) is a clinically and genetically heterogeneous group of neurodegenerative diseases characterized by the abnormal accumulation of brain iron and the progressive degeneration of the nervous system. One of the recently identified subtypes of NBIA is β-propeller protein-associated neurodegeneration (BPAN). BPAN is caused by de novo mutations in the WDR45/WIPI4 (WD repeat domain 45) gene. WDR45 is one of the four mammalian homologs of yeast Atg18, a regulator of autophagy. WDR45 deficiency in BPAN patients and animal models may result in defects in autophagic flux. However, how WDR45 deficiency leads to brain iron overload remains unclear. To elucidate the role of WDR45, we generated a WDR45-knockout (KO) SH-SY5Y neuroblastoma cell line using CRISPR-Cas9-mediated genome editing. Using these cells, we demonstrated that the non-TF (transferrin)-bound iron pathway dominantly mediated the accumulation of iron. Moreover, the loss of WDR45 led to defects in ferritinophagy, a form of autophagy that degrades the iron storage protein ferritin. We showed that impaired ferritinophagy contributes to iron accumulation in WDR45-KO cells. Iron accumulation was also detected in the mitochondria, which was accompanied by impaired mitochondrial respiration, elevated reactive oxygen species, and increased cell death. Thus, our study links WDR45 to specific iron acquisition pathways and ferritinophagy. Cover Image for this issue: https://doi.org/10.1111/jnc.15388.

Related Papers

• → Transferrin receptor 2: a new molecule in iron metabolism(2003)93 cited
• → Lymphocyte Proliferation Is Controlled by both Iron Availability and Regulation of Iron Uptake Pathways(1992)68 cited
• → [22] Receptor assay with radiolabeled transferrin(1987)13 cited
• → Species specificity of iron delivery in hybridomas(1988)11 cited
• → Commentary: Mutations of Transferrin Receptor 2 (Trf-2) and Iron Storage Disease(2001)2 cited